Heart failure (HF) and liver disease often co-exist. This is because systemic disorders and
diseases affect both organs (alcohol abuse, drugs, inflammation, autoimmunity, infections) …

The liver is a crucial metabolic organ that has a key role in maintaining immune and
endocrine homeostasis. Accumulating evidence suggests that chronic liver disease might …

The majority of patients on a waiting list for liver transplantation have end‐stage liver
disease. Because of the marked peripheral vasodilatation of end‐stage cirrhosis that masks …

Transjugular intrahepatic portosystemic shunt (TIPS) represents a very effective treatment of
complications of portal hypertension. Established indications to TIPS in cirrhotic patients …

Cardiac dysfunction in patients with liver cirrhosis is strongly associated with increased
serum bile acid concentrations. Here we show that excess bile acids decrease fatty acid …

Abstract Background and Aims Recently published criteria by 2019 Cirrhotic
Cardiomyopathy Consortium set a lower threshold for reduced ejection fraction to diagnose …

Introduction: Fulfillment of the diagnostic criteria for-hepatorenal syndrome type 1 (HRS-1)
requires prior failure of 2 days of intravenous volume expansion and/or diuretic withdrawal …

Patients with cirrhosis are prone to develop acute kidney injury (AKI), a complication
associated with a markedly increased in-hospital morbidity and mortality, along with a risk of …

Cirrhotic cardiomyopathy in end‐stage liver disease is currently characterized by blunted
contractile systolic response to stress with or without diastolic dysfunction in the absence of …